⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial
globenewswire.com
SNY
REGN
Longwood Healthcare Leaders to Host MIT CEO, Off-the-Record Networking and Discussion Forum, Convening Life Science Thought Leaders at MIT Koch Institute
accessnewswire.com
BIIB
ALNY
MRNA
REGN
JNJ
BEAM
IONS
Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight
globenewswire.com
TMO
CRL
REGN
BNTX
MRNA
GSK
SCLX
Emerging Drugs Market to Reach $558.0 Billion by 2030, Driven by Biologics Innovation and Regulatory Support
globenewswire.com
PFE
MRK
AMGN
JNJ
VRTX
REGN
Global Experts call for Paradigm Shift in Medicine, Health and Education to Save Lives and Fight Escalating Health Crisis
accessnewswire.com
BMY
MRK
PFE
JNJ
ABBV
AMGN
GILD
REGN
BIIB
LLY
Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight
globenewswire.com
AZN
IONS
ARWR
REGN
SNY
OMER
La expansión de ESTEVE en EU y EEUU impulsa crecimiento y consolidación como farmacéutica global USA - español USA - English Portugal - Português
prnewswire.com
REGN
ESTEVE'S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY
prnewswire.com
REGN
The Power of Community to Improve Asthma and Allergy Health
globenewswire.com
AMGN
GNE
SNY
REGN
Form 8-K
sec.gov
REGN